DERMA NATURA LTD
Opportunity 70/100 (strong), bankability 65/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: low (52/100)Sparse data coverage. Treat AI-generated outputs as preliminary. Manual diligence essential.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Recent activity
- • 1 address
- • 1 incorporation
- • 1 address
- • 1 incorporation
Corporate timeline (4 events)Click to expand
- 2026-03-17🏢Company incorporatedAs DERMA NATURA LTD
- 2026-03-17➕CUNNINGHAM, Erika Elise appointeddirector
- 2026-03-17📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2026-03-17📄incorporation-companyincorporation · NEWINC
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +Young company: Only 0.1 years old — management layer unlikely to be developed.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
Red flags
cleanShareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Erika Elise Cunningham Individual · British · DOB 04/1995 · age 31 | 75–100% | 75–100% | board control75-100% shares · 75-100% voting · board control | 17/03/2026 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · ML postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| CASHMERE AESTHETICS LTD→ SC664005 · est 2020 · no financials extracted | — | — | — | — | 5y | — | — |
| CASTLEHILL CARE HOME LIMITED→ SC601969 · est 2018 · no financials extracted | — | — | — | — | 7y | — | — |
| DAISY DAY CARE LIMITED→ SC402032 · est 2011 · no financials extracted | — | — | — | — | 14y | — | — |
| DR BARTEK CLINIC LTD→ SC838772 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
| DUNPATH CIC→ SC881712 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| EDEN MIND THERAPY LIMITED→ SC875751 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| EMPATHY ROOMS LIMITED→ SC515235 · est 2015 · no financials extracted | — | — | — | — | 10y | — | — |
| EMPOWER CARE SCOTLAND LTD.→ SC207039 · est 2000 · no financials extracted | — | — | — | — | 25y | — | — |
| ENABLE SCOTLAND→ SC278976 · est 2005 · no financials extracted | — | — | — | — | 21y | — | — |
| ENDOSCOT LIMITED→ SC625645 · est 2019 · no financials extracted | — | — | — | — | 7y | — | — |
| ENHANCE HEALTHCARE ADAM HOUSE LTD→ SC487965 · est 2014 · no financials extracted | — | — | — | — | 11y | — | — |
| ENHANCE HEALTHCARE ARDENCRAIG LTD→ SC847595 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 0 resigned)
Click a director name to see their full track record across all companies.